Fig. 1 · Structure
Documents & Downloads
NHS-PEG-NHS
PEG Derivative
NHS-PEG-NHS is a polyethylene glycol (PEG) derivative that serves as a bioconjugation modification reagent. It facilitates the conjugation of various biomolecules, including proteins, enzymes, peptides, and antibodies. This reagent is ideal for enhancing the solubility and stability of conjugated products, making it valuable for applications in drug development and protein engineering.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 122375-06-8 |
| Applications | PEG Derivative |
| Formula | (C2H4O)nC10H8N2O9 |
| SMILES | O=C(OCCOC(ON1C(CCC1=O)=O)=O)ON2C(CCC2=O)=O.[n] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.